FOLD
Amicus Therapeutics Inc.
$9.03
+$0.13(+1.46%)
58
Overall
20
Value
91
Tech
65
Quality
Market Cap
$2.57B
Volume
4.89M
52W Range
$5.51 - $12.65
Target Price
$15.36
Key Metrics Overview
| Market Cap | $2.57B | P/E Ratio | 301.00 |
| 52W High | $12.65 | 52W Low | $5.51 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 41.9% | 52W Position | 49.3% |
| Overall Score | 58 | Value Score | 20 |
| Quality Score | 65 | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $0.03 | EPS Next Est | $0.41 |
| EPS Growth Est | +1266.7% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FOLD | $9.03 | +1.5% | 4.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Amicus Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW